Nephritis and Onconephrology

Onco nephrology is an emerging subspecialty of nephrology. "The American Society of Nephrology (ASN) made a discussion committed to the field of onconephrology in 2011 to improve collaborative care after malignancy patients with kidney infection." Randomized controlled trials in a subspecialty like onconephrology can only be possible when there is collaboration amongst nephrologists and cancer physicians  from cancer centers around the world that interact and share research ideas at international meetings. This has led nephrologists to encounter new and partially unrecognized treatments of the targeted therapy agents with kidney adverse effects. These agents fall mainly into 2 categories affecting the vascular endothelial growth factor and endothelial growth factor pathways. An exciting era in the diagnosis and treatment of cancer has emerged in the last 2 decades. What was once an often deadly disease has, for many patients, become a chronic disease with longer survival than ever before. However, with the prolongation of life there are additionally related complications, for example, chronic kidney disease (CKD). This disease has impacts on the patients’ treatments, dosage of medications, quality of life, and overall survival. Nephritis is inflammation of the kidney the most important prevalent to acute nephritis is glomerulonephritis. Pyelonephritis that affects in adults more than children and it is recognized as inflammation of the kidney and upper urinary tract. A third type of nephritis is hereditary nephritis, a rare inherited condition.

 

    Related Conference of Nephritis and Onconephrology

    Nephritis and Onconephrology Conference Speakers